• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PDLIM2 通过 COP9 信号小体调节上皮-间充质转化中的转录因子活性。

PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.

机构信息

Cell Biology Laboratory, Department of Biochemistry, BioSciences Institute, University College Cork, Cork, Ireland Pfizer-Universidad de Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO), Granada 18016, Spain.

出版信息

Mol Biol Cell. 2014 Jan;25(1):184-95. doi: 10.1091/mbc.E13-06-0306. Epub 2013 Nov 6.

DOI:10.1091/mbc.E13-06-0306
PMID:24196835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3873889/
Abstract

Epithelial cell differentiation and polarized migration associated with epithelial-to-mesenchymal transition (EMT) in cancer requires integration of gene expression with cytoskeletal dynamics. Here we show that the PDZ-LIM domain protein PDLIM2 (Mystique/SLIM), a known cytoskeletal protein and promoter of nuclear nuclear factor κB (NFκB) and signal transducer and activator of transcription (STAT) degradation, regulates transcription factor activity and gene expression through the COP9 signalosome (CSN). Although repressed in certain cancers, PDLIM2 is highly expressed in invasive cancer cells. Here we show that PDLIM2 suppression causes loss of directional migration, inability to polarize the cytoskeleton, and reversal of the EMT phenotype. This is accompanied by altered activity of several transcription factor families, including β-catenin, Ap-1, NFκB, interferon regulatory factors, STATs, JUN, and p53. We also show that PDLIM2 associates with CSN5, and cells with suppressed PDLIM2 exhibit reduced nuclear accumulation and deneddylation activity of the CSN toward the cullin 1 and cullin 3 subunits of cullin-RING ubiquitin ligases. Thus PDLIM2 integrates cytoskeleton signaling with gene expression in epithelial differentiation by controlling the stability of key transcription factors and CSN activity.

摘要

上皮细胞分化和极化迁移与癌症中的上皮-间充质转化 (EMT) 相关,需要将基因表达与细胞骨架动力学整合。在这里,我们表明 PDZ-LIM 域蛋白 PDLIM2(神秘/SLIM),一种已知的细胞骨架蛋白和核因子 κB(NFκB)和信号转导和转录激活因子(STAT)降解的启动子,通过 COP9 信号体(CSN)调节转录因子活性和基因表达。尽管在某些癌症中受到抑制,但 PDLIM2 在侵袭性癌细胞中高度表达。在这里,我们表明 PDLIM2 的抑制导致定向迁移丧失、无法极化细胞骨架以及 EMT 表型的逆转。这伴随着几个转录因子家族的活性改变,包括β-catenin、Ap-1、NFκB、干扰素调节因子、STATs、JUN 和 p53。我们还表明 PDLIM2 与 CSN5 相关,并且抑制 PDLIM2 的细胞表现出核积累减少和 CSN 对 cullin-RING 泛素连接酶的 cullin 1 和 cullin 3 亚基的去泛素化活性降低。因此,PDLIM2 通过控制关键转录因子的稳定性和 CSN 活性,将细胞骨架信号与上皮分化中的基因表达整合在一起。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/f4f21c93c55f/184fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/be8a603c1460/184fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/7f0470238218/184fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/d3d15e789d7d/184fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/dac171b27ced/184fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/a41ad1dd6d10/184fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/d50ef8918409/184fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/3d6f72d11f63/184fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/f4f21c93c55f/184fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/be8a603c1460/184fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/7f0470238218/184fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/d3d15e789d7d/184fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/dac171b27ced/184fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/a41ad1dd6d10/184fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/d50ef8918409/184fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/3d6f72d11f63/184fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1356/3873889/f4f21c93c55f/184fig8.jpg

相似文献

1
PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.PDLIM2 通过 COP9 信号小体调节上皮-间充质转化中的转录因子活性。
Mol Biol Cell. 2014 Jan;25(1):184-95. doi: 10.1091/mbc.E13-06-0306. Epub 2013 Nov 6.
2
Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.PDLIM2 通过反馈调节β1 整联蛋白-RhoA 信号轴在三维培养物中的细胞极化中的必需功能。
Neoplasia. 2014 May;16(5):422-31. doi: 10.1016/j.neo.2014.04.006. Epub 2014 May 23.
3
Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.PDLIM2在单核细胞/巨噬细胞的细胞质中隔离与黏附以及核因子-κB的核活性增加有关。
J Leukoc Biol. 2009 Mar;85(3):481-90. doi: 10.1189/jlb.0408238. Epub 2008 Dec 3.
4
[PDLIM2 and Its Role in Oncogenesis--Tumor Suppressor or Oncoprote?].[PDLIM2 及其在肿瘤发生中的作用——肿瘤抑制因子还是癌蛋白?]
Klin Onkol. 2015;28 Suppl 2:2S40-6. doi: 10.14735/amko20152s40.
5
Roles of COP9 signalosome in cancer.COP9 信号osome 在癌症中的作用。
Cell Cycle. 2011 Sep 15;10(18):3057-66. doi: 10.4161/cc.10.18.17320.
6
Structural and biochemical characterization of the Cop9 signalosome CSN5/CSN6 heterodimer.COP9信号体CSN5/CSN6异二聚体的结构与生化特性
PLoS One. 2014 Aug 21;9(8):e105688. doi: 10.1371/journal.pone.0105688. eCollection 2014.
7
Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.COP9信号体(CSN)亚基在K562细胞中的作用分析;CSN与自噬之间的首个联系。
BMC Cell Biol. 2009 Apr 28;10:31. doi: 10.1186/1471-2121-10-31.
8
Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome.NF-κB 激活激酶复合物与 CSN 信号体之间的串扰。
J Cell Mol Med. 2010 Jun;14(6B):1555-68. doi: 10.1111/j.1582-4934.2009.00866.x. Epub 2009 Jul 28.
9
Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability.COP9信号体亚基的下调对COP9信号复合体和靶蛋白稳定性有不同影响。
BMC Biochem. 2007 Dec 19;8:27. doi: 10.1186/1471-2091-8-27.
10
IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5.通过磷酸化 CSN5 调节 COP9 信号体复合物中的 IKK 。
J Proteome Res. 2020 Mar 6;19(3):1119-1130. doi: 10.1021/acs.jproteome.9b00626. Epub 2020 Feb 3.

引用本文的文献

1
Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation.下调 PDLIM2 可促进肿瘤生长,涉及线粒体 ROS、致癌代谢物积累和 HIF-1α 激活。
J Exp Clin Cancer Res. 2024 Jun 17;43(1):169. doi: 10.1186/s13046-024-03094-9.
2
PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development.PDZ和LIM结构域编码基因:它们在癌症发展中的作用。
Cancers (Basel). 2023 Oct 19;15(20):5042. doi: 10.3390/cancers15205042.
3
Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders.

本文引用的文献

1
PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.PDLIM2 的表达受维生素 D 驱动,参与维生素 D 的促黏附、抗迁移和抗侵袭活性。
Oncogene. 2014 Apr 10;33(15):1904-11. doi: 10.1038/onc.2013.123. Epub 2013 Apr 15.
2
Regulatory networks defining EMT during cancer initiation and progression.在癌症起始和进展过程中定义 EMT 的调控网络。
Nat Rev Cancer. 2013 Feb;13(2):97-110. doi: 10.1038/nrc3447.
3
LIM-domain-only proteins in cancer.LIM 结构域蛋白与癌症。
JAB1 在神经发育和疾病中的调控机制及治疗潜力。
Mol Med. 2023 Jun 26;29(1):80. doi: 10.1186/s10020-023-00675-w.
4
The unexpected versatility of ALP/Enigma family proteins.碱性磷酸酶/谜蛋白家族蛋白出人意料的多功能性。
Front Cell Dev Biol. 2022 Dec 1;10:963608. doi: 10.3389/fcell.2022.963608. eCollection 2022.
5
PDLIM2 is highly expressed in Breast Cancer tumour-associated macrophages and is required for M2 macrophage polarization.PDLIM2在乳腺癌肿瘤相关巨噬细胞中高表达,是M2巨噬细胞极化所必需的。
Front Oncol. 2022 Nov 30;12:1028959. doi: 10.3389/fonc.2022.1028959. eCollection 2022.
6
High Expression of PDLIM2 Predicts a Poor Prognosis in Prostate Cancer and Is Correlated with Epithelial-Mesenchymal Transition and Immune Cell Infiltration.PDLIM2 高表达预示前列腺癌预后不良,并与上皮-间充质转化和免疫细胞浸润相关。
J Immunol Res. 2022 Jun 6;2022:2922832. doi: 10.1155/2022/2922832. eCollection 2022.
7
Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types.系统评价 PDLIM2 在 33 种癌症类型中的预后和免疫作用。
Sci Rep. 2022 Feb 4;12(1):1933. doi: 10.1038/s41598-022-05987-1.
8
PDLIM2: Signaling pathways and functions in cancer suppression and host immunity.PDLIM2:在癌症抑制和宿主免疫中的信号通路和功能。
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188630. doi: 10.1016/j.bbcan.2021.188630. Epub 2021 Sep 25.
9
Central Nervous System-Infecting Pathogens Escherichia coli and Cryptococcus neoformans Exploit the Host Pdlim2 for Intracellular Traversal and Exocytosis in the Blood-Brain Barrier.中枢神经系统感染病原体大肠杆菌和新型隐球菌利用宿主 Pdlim2 在血脑屏障中进行细胞内穿越和胞吐作用。
Infect Immun. 2021 Sep 16;89(10):e0012821. doi: 10.1128/IAI.00128-21. Epub 2021 Jul 6.
10
PDLIM2 Suppression Inhibit Proliferation and Metastasis in Kidney Cancer.PDLIM2抑制可抑制肾癌的增殖和转移。
Cancers (Basel). 2021 Jun 15;13(12):2991. doi: 10.3390/cancers13122991.
Nat Rev Cancer. 2013 Feb;13(2):111-22. doi: 10.1038/nrc3418. Epub 2013 Jan 10.
4
Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.上皮-间充质转化的时空调控对鳞状细胞癌转移至关重要。
Cancer Cell. 2012 Dec 11;22(6):725-36. doi: 10.1016/j.ccr.2012.09.022. Epub 2012 Nov 29.
5
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.PDLIM2 限制 Th1 和 Th17 分化,防止自身免疫性疾病。
Cell Biosci. 2012 Jun 25;2(1):23. doi: 10.1186/2045-3701-2-23.
6
The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity.上皮-间充质转化的调控:调节上皮可塑性的全局调控程序。
Semin Cancer Biol. 2012 Oct;22(5-6):361-8. doi: 10.1016/j.semcancer.2012.05.003. Epub 2012 May 18.
7
PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3.PDLIM2 通过降解 STAT3 抑制辅助性 T 细胞 17 细胞的发育和肉芽肿性炎症。
Sci Signal. 2011 Dec 6;4(202):ra85. doi: 10.1126/scisignal.2001637.
8
Id1 maintains embryonic stem cell self-renewal by up-regulation of Nanog and repression of Brachyury expression.Id1 通过上调 Nanog 和抑制 Brachyury 表达来维持胚胎干细胞自我更新。
Stem Cells Dev. 2012 Feb 10;21(3):384-93. doi: 10.1089/scd.2011.0428. Epub 2011 Dec 1.
9
Roles of COP9 signalosome in cancer.COP9 信号osome 在癌症中的作用。
Cell Cycle. 2011 Sep 15;10(18):3057-66. doi: 10.4161/cc.10.18.17320.
10
JAB1/CSN5: a new player in cell cycle control and cancer.JAB1/CSN5:细胞周期调控和癌症的新角色
Cell Div. 2010 Oct 18;5:26. doi: 10.1186/1747-1028-5-26.